Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism (2013)
- Authors:
- USP affiliated authors: ROMANO, MINNA MOREIRA DIAS - FMRP ; GERLACH, RAQUEL FERNANDA - FORP ; MACIEL, BENEDITO CARLOS - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FMRP; FORP
- DOI: 10.1111/jcmm.12163
- Subjects: TROMBOEMBOLISMO; METALOPROTEINASES; HIPERTENSÃO PULMONAR; MIOCARDIOPATIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Cellular and Molecular Medicine
- ISSN: 1582-1838
- Volume/Número/Paginação/Ano: v. 17, n. 12, p. 1588-1597, 2013
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
NETO-NEVES, Evandro M. et al. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Journal of Cellular and Molecular Medicine, v. 17, n. 12, p. 1588-1597, 2013Tradução . . Disponível em: https://doi.org/10.1111/jcmm.12163. Acesso em: 11 mar. 2026. -
APA
Neto-Neves, E. M., Sousa-Santos, O., Ferraz, K. C., Rizzi, E., Ceron, C. S., Romano, M. M. D., et al. (2013). Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Journal of Cellular and Molecular Medicine, 17( 12), 1588-1597. doi:10.1111/jcmm.12163 -
NLM
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MMD, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 12): 1588-1597.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1111/jcmm.12163 -
Vancouver
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MMD, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 12): 1588-1597.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1111/jcmm.12163 - Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
